University of Pittsburgh receives $1.3 million from NIH to develop promising avian flu vaccine (EurekAlert!) PITTSBURGH, Aug. 28– The National Institute of Allergy and Infectious Diseases (NIAID), of the National Institutes of Health in Bethesda, Md., has awarded a $1.3 million, two-year grant to the University of Pittsburgh School of Medicine to produce a promising avian flu vaccine that could be used in Phase I and Phase II human clinical trials. [News Source]